Atlas Trials

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Clinical trial NCT03257761 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03257761
Sponsor
University of Southern California
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Extrahepatic Bile Duct Adenocarcinoma, Biliary TypeGallbladder Adenocarcinoma, Biliary TypeMetastatic Pancreatic AdenocarcinomaRecurrent CholangiocarcinomaRecurrent Gallbladder CarcinomaRecurrent Hepatocellular CarcinomaRecurrent Intrahepatic CholangiocarcinomaRecurrent Pancreatic CarcinomaStage III Gallbladder Cancer AJCC V7Stage III Hepatocellular Carcinoma AJCC v7Stage III Intrahepatic Cholangiocarcinoma AJCC v7Stage III Pancreatic Cancer AJCC v6 and v7
Start date
2018-02-07
Primary completion
2021-09-27
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.